eMJA     The Medical Journal of Australia

Home | Issues | eMJA shop | My account | Classifieds | Contact | More... | Topics | Search   

Letters

Should radiologists and pathologists talk to patients?

Ibrahim M Zardawi
MJA 2002 177 (4): 222

To the Editor: The practice of radiology and pathology has changed dramatically in the past two decades. Increased use of multidisciplinary assessments and interventional techniques has meant greater exposure of patients to radiologists and pathologists. When patients undergo investigations, they are invariably anxious, usually expect the worst, and want the result as soon as possible. Therefore, there is pressure to provide an immediate answer to the problem at hand. In most instances, it would be possible to offer a diagnosis. However, many radiologists and pathologists are reluctant to discuss investigations with patients in detail.1

During interventional procedures, radiologists and pathologists see patients only briefly; they often don't know all the facts about them, and are not ultimately responsible for their clinical management.1 As the patient is only temporarily in the care of the radiologist or the pathologist, it is not appropriate to discuss complex issues or offer opinions and advice. Such advice may put the patient's doctor in an awkward position, forcing the referring practitioner to follow a course of action which may not be in the best interests of the patient.

At a patient's insistence, radiologists and pathologists can sometimes indicate to someone who has a clearly benign condition that the problem under investigation is unlikely to be serious.2-4 This may be the case with screening mammography, as, in most cases, the results are either normal or indicate a non-malignant condition. However, in diagnostic radiology and pathology, such an opinion is usually based on a preliminary impression, which may change when all the facts are considered.

The cost of providing on-the-spot written reports to the patient has to be factored into the equation. It has been estimated that the additional cost of immediate reporting of results of screening mammography is about US$28.22. When additional equipment and space were not required, the cost would increase by US$4.38. Although most patients in the study preferred immediate reporting, they were unwilling to pay the additional fees.5 With respect to pathology, a formal fine-needle aspiration result can be delivered within an hour, but, for the reasons outlined above, this would not be advisable. Further, the pathologist's contract is with the referring doctor and the report is written in scientific language, which may not be easily understood by the patient, leading to unnecessary anxiety.

Giving bad news to a patient is not an easy task even for trained professionals. It is even harder for radiologists and pathologists who are not generally equipped to provide counselling and support, and who may not be indemnified by their insurers to carry out such tasks. Further, neither radiology departments nor pathology laboratories are suitable settings for giving bad news,1 as very few support avenues are usually available to patients there.

Predicting the impact that bad news will have on a patient is extremely difficult, and radiologists and pathologists should, for compassionate and for medicolegal reasons, refrain from providing immediate answers to patients.

  1. Valley SR, Manton Mills JO. Should radiologists talk to patients? BMJ 1990; 300: 305-306. <PubMed>
  2. Bury RF. Should radiologists talk to patients? BMJ 1990; 300: 610.
  3. Charig M. Should radiologists talk to patients? BMJ 1990; 300: 610.
  4. Watt PCH, Caughley L, Varma M. Should pathologists talk to patients? BMJ 1990; 300: 1079.
  5. Raza S, Rosen MP, Chorney K, et al. Patient expectation and cost of immediate reporting of screening mammography: talk isn't cheap. Am J Roentgenol 2001; 177: 579-583.

(Received 22 Apr 2002, accepted 6 Jun 2002)

Mayne Health, Laverty Pathology, Newcastle Laboratory, Newcastle, NSW.

Ibrahim M Zardawi, MB ChB, MSc, FRCPA, FRCPath, FIAC, EBPC, Medical Director.

Correspondence: Dr Ibrahim M Zardawi, Mayne Health, Laverty Pathology, Newcastle Laboratory, PO Box 801, Newcastle, NSW 2300. ibrahim.zardawiATmaynegroup.com

Home | Issues | eMJA shop | My account | Classifieds | More... | Contact | Topics | Search

The Medical Journal of Australia    eMJA  

©The Medical Journal of Australia 2002 www.mja.com.au PRINT ISSN: 0025-729X ONLINE ISSN: 1326-5377